Pharmaceutical

SAB Biotherapeutics to Present at the American Diabetes Association 84th Scientific Sessions

MIAMI, June 18, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with…

1 month ago

Acentra Health Names Heather Adamson as Senior Vice President of Marketing

Heather Adamson, SVP, Marketing, Acentra Health Heather Adamson joins Acentra Health as SVP of Marketing. MCLEAN, Va., June 18, 2024…

1 month ago

Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting

Pratteln, Switzerland, June 18, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders approved all motions by the Board of…

1 month ago

Kriya Appoints Katherine Eade as Chief Legal Officer

– Experienced biopharma executive to guide Kriya’s overarching legal strategy across corporate affairs, gene therapy R&D, and technology & manufacturing…

1 month ago

Rapid Dose Provides Update on Common Share Private Placement

Burlington, Ontario--(Newsfile Corp. - June 19, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that…

1 month ago

Gareth Williams appointed CEO of Bionical Health

WILLINGTON, England, June 19, 2024 /PRNewswire/ -- Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to…

1 month ago

Tang Prize in Biopharmaceutical Science Honoring Three Scientists

TAIPEI, June 19, 2024 /PRNewswire/ -- In a continuing series of laureate announcements, the Tang Prize Foundation today (June 19th) announced…

1 month ago

Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2024 Conference Call

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 18, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host…

1 month ago

IntegriChain Acquires BridgeView Data Solutions, Creating the Pharmaceutical Industry’s Best-in-Class Commercial Data Solution

Combined entity delivers the ICyte® revenue optimization platform powered by first-party data, AI-enabled data exploration, and field intelligence and alerting…

1 month ago

Cosmo’s Oral Diagnostic Drug Lumeblue(R) Receives Approval of New Drug Application in China

Dublin, Ireland--(Newsfile Corp. - June 18, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) reported that its partner…

1 month ago